Nov. 29, 2012—The machinery that builds the characteristic shape of epithelial cells suppresses breast cancer formation and metastasis in a mouse model.
Nov. 29, 2012—It was, everyone agreed, a horrific end to a beautiful life.
Nov. 29, 2012—Carol Ann Gavin became critically ill on Super Bowl Sunday in 2010 while vacationing in Florida. But after two surgeries for a bowel obstruction at a Florida hospital, her husband, Charles Gavin III, asked that she be flown home to Vanderbilt University Medical Center, where he knew she would get unequaled health care at one of finest medical centers in the country.
Nov. 15, 2012—Vanderbilt University Medical Center investigators have received a $2.8 million grant from the National Heart, Lung, and Blood Institute (NHLBI) to continue studying ways to improve sedation management for intensive care unit patients who are on mechanical ventilators.
Nov. 15, 2012—Antioxidants promote cell growth in a mouse model of prostate cancer, Vanderbilt researchers report in the journal PLoS ONE. The findings provide insight into the recent controversy regarding antioxidants and prostate cancer prevention.
Nov. 15, 2012—Vanderbilt University Medical Center Nursing conducted its 2012 Bylaws Convention earlier this week. The Nursing Bylaws are reviewed and amended every two years to ensure they are an up-to-date governing guide for VUMC’s nearly 6,000-member nursing workforce.
Nov. 12, 2012—After serving more than 28 years as dean of the Vanderbilt University School of Nursing (VUSN), and as the second longest sitting dean of any U.S. nursing school, Colleen Conway-Welch, Ph.D., CNM, the Nancy and Hilliard Travis Professor of Nursing and a national leader in nursing education, will retire from this role at the end...
Nov. 8, 2012—There are many reasons why David Shaffer, M.D., surgical director of the Kidney Transplantation Program at Vanderbilt University Medical Center, loves his job.
Nov. 8, 2012—Vanderbilt University Hospital and Vanderbilt’s adult clinics have achieved a strong position in the region and are poised for continued growth.
Nov. 8, 2012—Patients prescribed the diabetes drug metformin have a lower risk for heart attack, stroke and death than patients taking sulfonylurea drugs.